Global Open Angle Glaucoma Drugs Market Research Report 2024

Publication ID:

PB503248660

Publication Date:

March 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.
The global Open Angle Glaucoma Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Open Angle Glaucoma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Open Angle Glaucoma Drugs.
Report Scope
The Open Angle Glaucoma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Open Angle Glaucoma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Open Angle Glaucoma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Allergan
Pfizer
Novartis
Bausch Health
Santen
Segment by Type
Prostaglandins
Carbonic Anhydrase Inhibitor
Cholinergic Drugs
Others
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Open Angle Glaucoma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Open Angle Glaucoma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Open Angle Glaucoma Drugs Market Overview
1.1 Product Overview and Scope of Open Angle Glaucoma Drugs
1.2 Open Angle Glaucoma Drugs Segment by Type
1.2.1 Global Open Angle Glaucoma Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Prostaglandins
1.2.3 Carbonic Anhydrase Inhibitor
1.2.4 Cholinergic Drugs
1.2.5 Others
1.3 Open Angle Glaucoma Drugs Segment by Application
1.3.1 Global Open Angle Glaucoma Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Open Angle Glaucoma Drugs Market Size Estimates and Forecasts
1.4.1 Global Open Angle Glaucoma Drugs Revenue 2019-2030
1.4.2 Global Open Angle Glaucoma Drugs Sales 2019-2030
1.4.3 Global Open Angle Glaucoma Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Open Angle Glaucoma Drugs Market Competition by Manufacturers
2.1 Global Open Angle Glaucoma Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Open Angle Glaucoma Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Open Angle Glaucoma Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Open Angle Glaucoma Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Open Angle Glaucoma Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Open Angle Glaucoma Drugs, Product Type & Application
2.7 Open Angle Glaucoma Drugs Market Competitive Situation and Trends
2.7.1 Open Angle Glaucoma Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Open Angle Glaucoma Drugs Players Market Share by Revenue
2.7.3 Global Open Angle Glaucoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Open Angle Glaucoma Drugs Retrospective Market Scenario by Region
3.1 Global Open Angle Glaucoma Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Open Angle Glaucoma Drugs Global Open Angle Glaucoma Drugs Sales by Region: 2019-2030
3.2.1 Global Open Angle Glaucoma Drugs Sales by Region: 2019-2024
3.2.2 Global Open Angle Glaucoma Drugs Sales by Region: 2025-2030
3.3 Global Open Angle Glaucoma Drugs Global Open Angle Glaucoma Drugs Revenue by Region: 2019-2030
3.3.1 Global Open Angle Glaucoma Drugs Revenue by Region: 2019-2024
3.3.2 Global Open Angle Glaucoma Drugs Revenue by Region: 2025-2030
3.4 North America Open Angle Glaucoma Drugs Market Facts & Figures by Country
3.4.1 North America Open Angle Glaucoma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Open Angle Glaucoma Drugs Sales by Country (2019-2030)
3.4.3 North America Open Angle Glaucoma Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Open Angle Glaucoma Drugs Market Facts & Figures by Country
3.5.1 Europe Open Angle Glaucoma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Open Angle Glaucoma Drugs Sales by Country (2019-2030)
3.5.3 Europe Open Angle Glaucoma Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Open Angle Glaucoma Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Open Angle Glaucoma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Open Angle Glaucoma Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Open Angle Glaucoma Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Open Angle Glaucoma Drugs Market Facts & Figures by Country
3.7.1 Latin America Open Angle Glaucoma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Open Angle Glaucoma Drugs Sales by Country (2019-2030)
3.7.3 Latin America Open Angle Glaucoma Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Open Angle Glaucoma Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Open Angle Glaucoma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Open Angle Glaucoma Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Open Angle Glaucoma Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Open Angle Glaucoma Drugs Sales by Type (2019-2030)
4.1.1 Global Open Angle Glaucoma Drugs Sales by Type (2019-2024)
4.1.2 Global Open Angle Glaucoma Drugs Sales by Type (2025-2030)
4.1.3 Global Open Angle Glaucoma Drugs Sales Market Share by Type (2019-2030)
4.2 Global Open Angle Glaucoma Drugs Revenue by Type (2019-2030)
4.2.1 Global Open Angle Glaucoma Drugs Revenue by Type (2019-2024)
4.2.2 Global Open Angle Glaucoma Drugs Revenue by Type (2025-2030)
4.2.3 Global Open Angle Glaucoma Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Open Angle Glaucoma Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Open Angle Glaucoma Drugs Sales by Application (2019-2030)
5.1.1 Global Open Angle Glaucoma Drugs Sales by Application (2019-2024)
5.1.2 Global Open Angle Glaucoma Drugs Sales by Application (2025-2030)
5.1.3 Global Open Angle Glaucoma Drugs Sales Market Share by Application (2019-2030)
5.2 Global Open Angle Glaucoma Drugs Revenue by Application (2019-2030)
5.2.1 Global Open Angle Glaucoma Drugs Revenue by Application (2019-2024)
5.2.2 Global Open Angle Glaucoma Drugs Revenue by Application (2025-2030)
5.2.3 Global Open Angle Glaucoma Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Open Angle Glaucoma Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Open Angle Glaucoma Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Open Angle Glaucoma Drugs Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Open Angle Glaucoma Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Open Angle Glaucoma Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Bausch Health
6.5.1 Bausch Health Corporation Information
6.5.2 Bausch Health Description and Business Overview
6.5.3 Bausch Health Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bausch Health Open Angle Glaucoma Drugs Product Portfolio
6.5.5 Bausch Health Recent Developments/Updates
6.6 Santen
6.6.1 Santen Corporation Information
6.6.2 Santen Description and Business Overview
6.6.3 Santen Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Santen Open Angle Glaucoma Drugs Product Portfolio
6.6.5 Santen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Open Angle Glaucoma Drugs Industry Chain Analysis
7.2 Open Angle Glaucoma Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Open Angle Glaucoma Drugs Production Mode & Process
7.4 Open Angle Glaucoma Drugs Sales and Marketing
7.4.1 Open Angle Glaucoma Drugs Sales Channels
7.4.2 Open Angle Glaucoma Drugs Distributors
7.5 Open Angle Glaucoma Drugs Customers
8 Open Angle Glaucoma Drugs Market Dynamics
8.1 Open Angle Glaucoma Drugs Industry Trends
8.2 Open Angle Glaucoma Drugs Market Drivers
8.3 Open Angle Glaucoma Drugs Market Challenges
8.4 Open Angle Glaucoma Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
Allergan
Pfizer
Novartis
Bausch Health
Santen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂